欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号ES/V/0163/001
药品名称Wellplus Flavoured Tablets
活性成分
    • febantel 150.0 mg
    • praziquantel embonate 50.0 mg
    • pyrantel embonate 144.0 mg
剂型Tablet
上市许可持有人Divasa-Farmavic S.A. Ctra. Sant Hipolit Km 71 PO Box 79 08503 Gurb-Vic Spain
参考成员国 - 产品名称Spain (ES)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      Wellplus Flavoured Tablets for Dogs
    • Germany (DE)
      Wellplus
    • Belgium (BE)
      Wellplus
    • Netherlands (NL)
    • Ireland (IE)
      Wellplus Flavoured Tablets
    • Portugal (PT)
    • Greece (GR)
    • Poland (PL)
      Wellplus flavoured tablets for dogs
    • Bulgaria (BG)
    • Romania (RO)
    • Slovakia (SK)
许可日期2013/10/24
最近更新日期2020/06/22
药物ATC编码
    • QP52AA30 combinations of quinoline derivatives and related substances
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase